GB377518A
(en)
|
1931-10-31 |
1932-07-28 |
Fairweather Harold G C |
Improved steam or gas turbine plant
|
US2377237A
(en)
|
1940-08-03 |
1945-05-29 |
Corn Prod Refining Co |
Zein dispersions and processes of making same
|
US2507631A
(en)
|
1944-01-19 |
1950-05-16 |
Ciba Pharm Prod Inc |
Pyridine and piperidine compounds and process of making same
|
US2676169A
(en)
|
1951-09-26 |
1954-04-20 |
Corn Prod Refining Co |
Method of treating zein
|
US2791509A
(en)
|
1954-06-24 |
1957-05-07 |
Horace B Cosler |
Method of producing zein-coated confectionery
|
US2772488A
(en)
|
1955-07-20 |
1956-12-04 |
Meltzer Jack |
Shoe having covered insole body and nailed-on heel
|
DE1228757B
(de)
|
1962-06-28 |
1966-11-17 |
Haessle Ab |
Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
|
DE1228029C2
(de)
|
1964-05-09 |
1973-05-17 |
Merck Ag E |
Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
|
US3370054A
(en)
|
1965-03-05 |
1968-02-20 |
Interchem Corp |
Zein prepared by strong alkali hydrolysis of aqueous alcoholic zein solutions and subsequent acid precipitation of the alkali
|
US3365365A
(en)
|
1965-08-09 |
1968-01-23 |
Hoffmann La Roche |
Repeat action pharmaceutical compositions in the form of discrete beadlets
|
CH434571A
(de)
|
1966-07-05 |
1967-04-30 |
Chemical And Pharmaceutical Pa |
Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung
|
US4000254A
(en)
|
1966-04-25 |
1976-12-28 |
Schmid Laboratories, Inc. |
Fungimycin compositions
|
US3623997A
(en)
|
1966-06-06 |
1971-11-30 |
Ncr Co |
Wall-sealing treatment for minute capsules and minute capsules having walls of sealed polymeric material
|
NL131321C
(es)
|
1967-05-05 |
|
|
|
US4060598A
(en)
|
1967-06-28 |
1977-11-29 |
Boehringer Mannheim G.M.B.H. |
Tablets coated with aqueous resin dispersions
|
US3935326A
(en)
|
1967-06-28 |
1976-01-27 |
Boehringer Mannheim G.M.B.H. |
Process for coating tablets with aqueous resin dispersions
|
US3996356A
(en)
|
1969-07-02 |
1976-12-07 |
Hoffmann-La Roche Inc. |
Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
|
US3629393A
(en)
|
1969-09-11 |
1971-12-21 |
Nikken Chemicals Co Ltd |
Release-sustaining-tablet
|
US3870790A
(en)
|
1970-01-22 |
1975-03-11 |
Forest Laboratories |
Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
|
SE378109B
(es)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3883647A
(en)
|
1972-12-06 |
1975-05-13 |
Ives Lab |
Tablet formulation
|
JPS5831210B2
(ja)
|
1973-04-09 |
1983-07-05 |
武田薬品工業株式会社 |
アンテイナスイセイケンダクエキノセイゾウホウ
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
DE2336218C3
(de)
|
1973-07-17 |
1985-11-14 |
Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz |
Orale Arzneiform
|
US3901968A
(en)
|
1973-09-10 |
1975-08-26 |
Union Corp |
Sustained release of methantheline
|
US4093709A
(en)
|
1975-01-28 |
1978-06-06 |
Alza Corporation |
Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
|
US4088798A
(en)
|
1975-11-11 |
1978-05-09 |
Sandoz, Inc. |
Methods for the preparation of controlled gastric residence time medicament formulations
|
SE418247B
(sv)
|
1975-11-17 |
1981-05-18 |
Haessle Ab |
Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
|
US4167558A
(en)
|
1976-02-13 |
1979-09-11 |
Hoffmann-La Roche Inc. |
Novel sustained release tablet formulations
|
US4140755A
(en)
|
1976-02-13 |
1979-02-20 |
Hoffmann-La Roche Inc. |
Sustained release tablet formulations
|
SE418749B
(sv)
|
1977-04-04 |
1981-06-22 |
Ewos Ab |
Polymer for filmoverdragning av foderlivs- och lekemedel och med ph-beroende loslighetsegenskaper i vattenhaltiga medier samt forfarande for dess framstellning
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
US4182756A
(en)
|
1977-11-21 |
1980-01-08 |
Abbott Laboratories |
High calorie solutions of low molecular weight glucose polymer mixtures useful for intravenous administration
|
US4173626A
(en)
|
1978-12-11 |
1979-11-06 |
Merck & Co., Inc. |
Sustained release indomethacin
|
CH647676A5
(fr)
|
1978-12-22 |
1985-02-15 |
Donald E Panoz |
Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
|
JPS55149211A
(en)
|
1979-05-10 |
1980-11-20 |
Takeda Chem Ind Ltd |
Production of gradually releasable preparation
|
US4357469A
(en)
|
1979-06-14 |
1982-11-02 |
Forest Laboratories, Inc. |
Carrier base material for prolonged release therapeutic compositions
|
US4226849A
(en)
|
1979-06-14 |
1980-10-07 |
Forest Laboratories Inc. |
Sustained release therapeutic compositions
|
US4252786A
(en)
|
1979-11-16 |
1981-02-24 |
E. R. Squibb & Sons, Inc. |
Controlled release tablet
|
FR2470599A1
(fr)
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
|
US4259314A
(en)
|
1979-12-10 |
1981-03-31 |
Hans Lowey |
Method and composition for the preparation of controlled long-acting pharmaceuticals
|
US4318400A
(en)
|
1980-01-18 |
1982-03-09 |
Alza Corporation |
Medical infusor
|
SE8003805L
(sv)
|
1980-05-21 |
1981-11-22 |
Haessle Ab |
En farmaceutisk beredning med forbettrade utlosningsegenskap
|
SE8008524L
(sv)
|
1980-12-04 |
1982-06-05 |
Draco Ab |
4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
|
US4439453A
(en)
|
1980-12-22 |
1984-03-27 |
Monsanto Company |
Directly compressible acetaminophen granulation
|
JPS57120518A
(en)
|
1981-01-19 |
1982-07-27 |
Tanabe Seiyaku Co Ltd |
Preparation of microcapsule
|
DE3167521D1
(en)
|
1981-01-22 |
1985-01-17 |
Capsugel Ag |
A process for producing a pharmaceutical capsule having enteric properties
|
GB2098867B
(en)
|
1981-05-21 |
1984-10-24 |
Wyeth John & Brother Ltd |
Sustained release pharmaceutical composition
|
ZA825384B
(en)
|
1981-07-31 |
1983-05-25 |
Tillott J B Ltd |
Orally administrable pharmaceutical compositions
|
JPS5839618A
(ja)
|
1981-09-04 |
1983-03-08 |
Chugai Pharmaceut Co Ltd |
持続性積層錠剤
|
DK150008C
(da)
|
1981-11-20 |
1987-05-25 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
|
US4369172A
(en)
|
1981-12-18 |
1983-01-18 |
Forest Laboratories Inc. |
Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
|
DE3208791A1
(de)
|
1982-03-11 |
1983-09-22 |
Röhm GmbH, 6100 Darmstadt |
Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
|
US4389393A
(en)
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
US4634587A
(en)
|
1982-07-09 |
1987-01-06 |
Key Pharmaceuticals, Inc. |
Sustained release quinidine dosage form
|
DK152744C
(da)
|
1982-08-13 |
1988-10-31 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
|
US4464170A
(en)
|
1982-09-29 |
1984-08-07 |
Miles Laboratories, Inc. |
Blood glucose control apparatus and method
|
IE53703B1
(en)
|
1982-12-13 |
1989-01-18 |
Elan Corp Plc |
Drug delivery device
|
US4503031A
(en)
|
1982-12-17 |
1985-03-05 |
Glassman Jacob A |
Super-fast-starting-sustained release tablet
|
US4526777A
(en)
|
1983-01-06 |
1985-07-02 |
Mylan Pharmaceuticals Inc. |
Pharmaceutical combination composition and associated method
|
HU187215B
(en)
|
1983-01-26 |
1985-11-28 |
Egyt Gyogyszervegyeszeti Gyar |
Method for producing pharmaceutical product of high actor content and prolonged effect
|
IE55745B1
(en)
|
1983-04-06 |
1991-01-02 |
Elan Corp Plc |
Sustained absorption pharmaceutical composition
|
US4783337A
(en)
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
JPS601128A
(ja)
|
1983-06-15 |
1985-01-07 |
Shionogi & Co Ltd |
作用持続型セフアクロル製剤
|
US4501018A
(en)
|
1983-07-05 |
1985-02-19 |
Motorola, Inc. |
Simplex transceiver employing a common piezoelectric element for transmitting and receiving
|
US4548990A
(en)
|
1983-08-15 |
1985-10-22 |
Ciba-Geigy Corporation |
Crosslinked, porous polymers for controlled drug delivery
|
JPS6051106A
(ja)
|
1983-08-31 |
1985-03-22 |
Yamanouchi Pharmaceut Co Ltd |
塩酸アモスラロ−ル持続性製剤
|
DE3333639A1
(de)
|
1983-09-17 |
1985-03-28 |
Dynamit Nobel Ag |
Zubereitung von nitroestern fuer die koronartherapie
|
US4729190A
(en)
|
1983-10-27 |
1988-03-08 |
Ciba-Geigy Corporation |
Membrane-forming polymeric systems
|
US4708867A
(en)
|
1983-12-19 |
1987-11-24 |
Key Pharmaceuticals, Inc. |
Minipellets
|
IE56459B1
(en)
|
1983-12-21 |
1991-08-14 |
Elan Corp Ltd |
Controlled absorption pharmaceutical formulation
|
US4894240A
(en)
|
1983-12-22 |
1990-01-16 |
Elan Corporation Plc |
Controlled absorption diltiazem formulation for once-daily administration
|
US4917899A
(en)
|
1983-12-22 |
1990-04-17 |
Elan Corporation Plc |
Controlled absorption diltiazem formulation
|
IE56999B1
(en)
|
1983-12-22 |
1992-03-11 |
Elan Corp Plc |
Pharmaceutical formulation
|
DE3403329A1
(de)
|
1984-02-01 |
1985-08-01 |
Horst Dr. 4019 Monheim Zerbe |
Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
|
IE59287B1
(en)
|
1984-02-10 |
1994-02-09 |
Benzon Pharma As |
Diffusion coated multiple-units dosage form
|
CH658188A5
(de)
|
1984-03-23 |
1986-10-31 |
Ciba Geigy Ag |
Lagerstabile schnellzerfallende pharmazeutische presslinge.
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
DE3580384D1
(de)
|
1984-04-09 |
1990-12-13 |
Toyo Boseki |
Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
|
GB2159715B
(en)
|
1984-06-04 |
1988-05-05 |
Sterwin Ag |
Pharmaceutical composition in sustained release unit dose form and process for its preparation
|
DE3581428D1
(de)
|
1984-06-13 |
1991-02-28 |
Roehm Gmbh |
Verfahren zum ueberziehen von arzneiformen.
|
JPS6124516A
(ja)
|
1984-07-12 |
1986-02-03 |
Fujisawa Pharmaceut Co Ltd |
持続性錠剤
|
DE3431861A1
(de)
|
1984-08-30 |
1986-03-13 |
Troponwerke GmbH & Co KG, 5000 Köln |
Pellet-zubereitung
|
US4863744A
(en)
|
1984-09-17 |
1989-09-05 |
Alza Corporation |
Intestine drug delivery
|
US4610870A
(en)
|
1984-10-05 |
1986-09-09 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
US4693895A
(en)
|
1984-10-26 |
1987-09-15 |
Alza Corporation |
Colon delivery system
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
US4867984A
(en)
|
1984-11-06 |
1989-09-19 |
Nagin K. Patel |
Drug in bead form and process for preparing same
|
US4606940A
(en)
|
1984-12-21 |
1986-08-19 |
The Ohio State University Research Foundation |
Small particle formation and encapsulation
|
US4600645A
(en)
|
1985-01-31 |
1986-07-15 |
Warner-Lambert Company |
Process for treating dosage forms
|
US4772475A
(en)
|
1985-03-08 |
1988-09-20 |
Yamanouchi Pharmaceutical Co., Ltd. |
Controlled-release multiple units pharmaceutical formulation
|
NL8500724A
(nl)
|
1985-03-13 |
1986-10-01 |
Univ Groningen |
Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
|
CH666405A5
(de)
|
1985-06-24 |
1988-07-29 |
Ciba Geigy Ag |
Feste, haltbare darreichungsformen mit elastischem filmueberzug.
|
GB8519310D0
(en)
|
1985-07-31 |
1985-09-04 |
Zyma Sa |
Granular active substances
|
IT1214629B
(it)
|
1985-08-29 |
1990-01-18 |
Formenti Farmaceutici Spa |
Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
|
US4710519A
(en)
|
1985-09-30 |
1987-12-01 |
Basf Corporation |
Process for preparing spray dried acetaminophen powder and the powder prepared thereby
|
DE3536267A1
(de)
|
1985-10-11 |
1987-04-16 |
Bayer Ag |
Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
|
US4837004A
(en)
|
1985-10-18 |
1989-06-06 |
Eastman Kodak Company |
Rumen-stable pellets
|
JPS62103012A
(ja)
|
1985-10-23 |
1987-05-13 |
Eisai Co Ltd |
多重顆粒
|
US4826688A
(en)
|
1985-11-13 |
1989-05-02 |
501 Elan Corporation PLC. |
Controlled absorption pharmaceutical formulation
|
US4892742A
(en)
|
1985-11-18 |
1990-01-09 |
Hoffmann-La Roche Inc. |
Controlled release compositions with zero order release
|
SE8506015D0
(sv)
|
1985-12-19 |
1985-12-19 |
Draco Ab |
Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
|
IT1188212B
(it)
|
1985-12-20 |
1988-01-07 |
Paolo Colombo |
Sistema per il rilascio a velocita' controllata di sostanze attive
|
IE63321B1
(en)
|
1986-02-03 |
1995-04-05 |
Elan Corp Plc |
Drug delivery system
|
GB2186485B
(en)
|
1986-02-13 |
1988-09-07 |
Ethical Pharma Ltd |
Slow release formulation
|
US4794001A
(en)
|
1986-03-04 |
1988-12-27 |
American Home Products Corporation |
Formulations providing three distinct releases
|
IT1204294B
(it)
|
1986-03-11 |
1989-03-01 |
Gentili Ist Spa |
Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
|
JPH0759496B2
(ja)
|
1986-03-25 |
1995-06-28 |
ロ−ト製薬株式会社 |
歯周病治療剤
|
AU591248B2
(en)
|
1986-03-27 |
1989-11-30 |
Kinaform Technology, Inc. |
Sustained-release pharaceutical preparation
|
US5026709A
(en)
|
1986-04-07 |
1991-06-25 |
Rorer Pharmaceutical Corporation |
Method for the preparation of a theophylline sustained release pharmaceutical composition and the composition prepared thereby
|
GB2189699A
(en)
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated acid-labile medicaments
|
GB2189698A
(en)
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
US4842867A
(en)
|
1986-05-09 |
1989-06-27 |
Alza Corporation |
Pulsed drug delivery of doxylamine
|
GB8613689D0
(en)
|
1986-06-05 |
1986-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
US4816264A
(en)
|
1986-06-06 |
1989-03-28 |
Warner-Lambert Company |
Sustained release formulations
|
EP0250374B1
(en)
|
1986-06-17 |
1991-05-02 |
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. |
Therapeutic system for controlled release of drugs
|
CH669523A5
(es)
|
1986-06-25 |
1989-03-31 |
Mepha Ag |
|
JPS6327424A
(ja)
|
1986-07-17 |
1988-02-05 |
Shionogi & Co Ltd |
徐放性製剤およびその製造法
|
US5374430A
(en)
|
1986-09-18 |
1994-12-20 |
London School Of Pharmacy |
Pharmaceutical formulation
|
IT1200217B
(it)
*
|
1986-09-30 |
1989-01-05 |
Valducci Roberto |
Membrana per uso farmaceutico ed industriale
|
IT1197316B
(it)
|
1986-10-01 |
1988-11-30 |
Proter Spa |
Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
|
GB8630913D0
(en)
|
1986-12-24 |
1987-02-04 |
Glaxo Group Ltd |
Pharmaceutical compositions
|
US5026560A
(en)
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
US5015479A
(en)
|
1987-02-02 |
1991-05-14 |
Seamus Mulligan |
Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine
|
US4940586A
(en)
|
1987-02-26 |
1990-07-10 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
GB8707416D0
(en)
|
1987-03-27 |
1987-04-29 |
Wellcome Found |
Pharmaceutical formulations
|
US4786503A
(en)
|
1987-04-06 |
1988-11-22 |
Alza Corporation |
Dosage form comprising parallel lamine
|
US5200193A
(en)
|
1987-04-22 |
1993-04-06 |
Mcneilab, Inc. |
Pharmaceutical sustained release matrix and process
|
JP2668880B2
(ja)
|
1987-06-23 |
1997-10-27 |
日本油脂株式会社 |
被覆アミノ酸類の製造方法
|
US4814178A
(en)
|
1987-07-01 |
1989-03-21 |
Sanford Bolton |
Floating sustained release therapeutic compositions
|
US4968509A
(en)
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
US5004613A
(en)
|
1987-07-27 |
1991-04-02 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
US4820522A
(en)
|
1987-07-27 |
1989-04-11 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
US5073380A
(en)
|
1987-07-27 |
1991-12-17 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
US4814181A
(en)
|
1987-09-03 |
1989-03-21 |
Alza Corporation |
Dosage form comprising fast agent delivery followed by slow agent delivery
|
US5068110A
(en)
|
1987-09-29 |
1991-11-26 |
Warner-Lambert Company |
Stabilization of enteric coated dosage form
|
US4950486A
(en)
|
1987-10-02 |
1990-08-21 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4811845A
(en)
|
1987-10-06 |
1989-03-14 |
Baggett Jobeth |
Medication compliance packaging system and procedure
|
US5219621A
(en)
|
1987-10-16 |
1993-06-15 |
Elan Corporation, Plc |
Methods of treatment with diltiazem formulations
|
GB8724763D0
(en)
|
1987-10-22 |
1987-11-25 |
Aps Research Ltd |
Sustained-release formulations
|
IE64726B1
(en)
|
1987-11-20 |
1995-08-23 |
Elan Corp Plc |
Pharmaceutical formulations for preventing drug tolerance
|
EP0325086A3
(en)
|
1987-11-23 |
1990-10-31 |
Jago Research Ag |
Novel methods for obtaining therapeutic systems with controlled release of the drug
|
FR2624351B1
(fr)
|
1987-12-15 |
1991-11-22 |
Rhone Poulenc Sante |
Compositions degradables par voie enzymatique utilisables pour l'enrobage d'additifs alimentaires destines aux ruminants
|
FR2624732B1
(fr)
|
1987-12-21 |
1991-02-15 |
Synthelabo |
Formulation pharmaceutique a liberation prolongee
|
US4971805A
(en)
|
1987-12-23 |
1990-11-20 |
Teysan Pharmaceuticals Co., Ltd. |
Slow-releasing granules and long acting mixed granules comprising the same
|
EP0327295A3
(en)
|
1988-02-01 |
1989-09-06 |
F.H. FAULDING & CO. LTD. |
Tetracycline dosage form
|
JP2643222B2
(ja)
|
1988-02-03 |
1997-08-20 |
エーザイ株式会社 |
多重層顆粒
|
US5095054A
(en)
|
1988-02-03 |
1992-03-10 |
Warner-Lambert Company |
Polymer compositions containing destructurized starch
|
GB8805695D0
(en)
|
1988-03-10 |
1988-04-07 |
Nycomed As |
Enteric coated spheroidal granules
|
US5019397A
(en)
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US4892739A
(en)
|
1988-04-25 |
1990-01-09 |
Ciba-Geigy Corporation |
Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
|
US5024842A
(en)
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US5160737A
(en)
|
1988-05-03 |
1992-11-03 |
Perio Products Ltd. |
Liquid polymer composition, and method of use
|
US4966769A
(en)
|
1988-06-02 |
1990-10-30 |
Alza Corporation |
Method for delivering dosage form for diltiazem
|
DE3827214A1
(de)
|
1988-08-11 |
1990-02-15 |
Roehm Gmbh |
Retardierte arzneiform und verfahren zu ihrer herstellung
|
JP2514078B2
(ja)
|
1988-08-22 |
1996-07-10 |
エスエス製薬株式会社 |
圧縮成型製剤
|
US5334372A
(en)
|
1988-10-07 |
1994-08-02 |
Kao Corporation |
Alcohol-modified silicon ester derivative and cosmetic composition containing same
|
IT1230576B
(it)
|
1988-10-20 |
1991-10-28 |
Angeli Inst Spa |
Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
|
US4931295A
(en)
|
1988-12-02 |
1990-06-05 |
Wm. Wrigley Jr. Company |
Chewing gum containing high-potency sweetener particles with modified zein coating
|
US5085866A
(en)
|
1988-12-02 |
1992-02-04 |
Southern Research Institute |
Method of producing zero-order controlled-released devices
|
FR2643572A1
(fr)
|
1988-12-22 |
1990-08-31 |
Rhone Poulenc Chimie |
Procede d'encapsulation de particules par pelliculage au moyen d'un copolymere silicone thermoplastique
|
CA2007055A1
(en)
|
1989-01-06 |
1990-07-06 |
Garth Boehm |
Theophylline dosage form
|
US5202128A
(en)
|
1989-01-06 |
1993-04-13 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
US5330766A
(en)
|
1989-01-06 |
1994-07-19 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
US4981468A
(en)
|
1989-02-17 |
1991-01-01 |
Eli Lilly And Company |
Delivery device for orally administered therapeutic agents
|
US5032406A
(en)
|
1989-02-21 |
1991-07-16 |
Norwich Eaton Pharmaceuticals, Inc. |
Dual-action tablet
|
US4889238A
(en)
|
1989-04-03 |
1989-12-26 |
The Procter & Gamble Company |
Medicament package for increasing compliance with complex therapeutic regimens
|
US5085865A
(en)
|
1989-04-12 |
1992-02-04 |
Warner-Lambert Company |
Sustained release pharmaceutical preparations containing an analgesic and a decongestant
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US4983401A
(en)
|
1989-05-22 |
1991-01-08 |
Kinaform Technology, Inc. |
Sustained release pharmaceutical preparations having pH controlled membrane coatings
|
US5084278A
(en)
|
1989-06-02 |
1992-01-28 |
Nortec Development Associates, Inc. |
Taste-masked pharmaceutical compositions
|
US5047258A
(en)
|
1989-07-14 |
1991-09-10 |
Sterling Drug Inc. |
Aqueous spray-coating process
|
US4966770A
(en)
|
1989-07-26 |
1990-10-30 |
Himedics, Inc. |
Prednisone microencapsulated granules
|
PH27186A
(en)
|
1989-09-07 |
1993-04-16 |
Ciba Geigy Ag |
Double-coated granules of disodium pamidronate
|
US5198228A
(en)
|
1989-09-14 |
1993-03-30 |
Hoechst-Roussel Pharmaceuticals Inc. |
Direct dry compressible acetaminophen tablet
|
US5130140A
(en)
|
1989-09-14 |
1992-07-14 |
Hoeschst-Roussel Pharmaceuticals Inc. |
Method of making direct dry compressible acetaminophen composition
|
DE69017915T2
(de)
|
1989-10-26 |
1995-07-27 |
Nippon Shinyaku Co Ltd |
Zubereitung für den magen.
|
US5643602A
(en)
|
1989-11-22 |
1997-07-01 |
Astra Aktiebolag |
Oral composition for the treatment of inflammatory bowel disease
|
FR2655266B1
(fr)
|
1989-12-05 |
1992-04-03 |
Smith Kline French Lab |
Compositions pharmaceutiques a base de cimetidine.
|
US4984592A
(en)
|
1989-12-18 |
1991-01-15 |
Christine Hellein |
Manicure shield
|
US5047007A
(en)
|
1989-12-22 |
1991-09-10 |
Medtronic, Inc. |
Method and apparatus for pulsed iontophoretic drug delivery
|
US5229131A
(en)
|
1990-02-05 |
1993-07-20 |
University Of Michigan |
Pulsatile drug delivery system
|
US5158777A
(en)
|
1990-02-16 |
1992-10-27 |
E. R. Squibb & Sons, Inc. |
Captopril formulation providing increased duration of activity
|
CA2036907C
(en)
|
1990-02-28 |
1996-10-22 |
Yuzo Miura |
3-(substituted phenyl) pyrazole derivatives, a process for producing the same, herbicidal composition containing the same and method of controlling weeds using said composition
|
IT1241417B
(it)
|
1990-03-06 |
1994-01-14 |
Vectorpharma Int |
Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
|
US5178866A
(en)
|
1990-03-23 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug to the intestine
|
JP2542122B2
(ja)
|
1990-04-18 |
1996-10-09 |
旭化成工業株式会社 |
球状核、球形顆粒およびその製造方法
|
SE469209B
(sv)
|
1990-05-04 |
1993-06-07 |
Anthony De Belder |
Terapeutisk komposition innehaallande hydrolyserad karboxialkylcellulosa
|
US5091175A
(en)
|
1990-05-14 |
1992-02-25 |
Erbamont Inc. |
Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
|
AU8050791A
(en)
|
1990-06-20 |
1992-01-07 |
Advanced Polymer Systems Inc. |
Compositions and methods for the controlled release of soluble active substances
|
JP2558396B2
(ja)
|
1990-06-28 |
1996-11-27 |
田辺製薬株式会社 |
放出制御型製剤
|
IE61651B1
(en)
|
1990-07-04 |
1994-11-16 |
Zambon Spa |
Programmed release oral solid pharmaceutical dosage form
|
UA26305A
(uk)
|
1990-07-16 |
1999-08-30 |
Аста Медіка Аг |
Таблетка, спосіб її одержаhhя, граhулят та спосіб одержаhhя граhулята
|
DE4122167A1
(de)
|
1990-07-16 |
1992-01-23 |
Asta Pharma Ag |
Tablette und granulat enthaltend als wirkstoff mesna
|
US5252341A
(en)
|
1990-07-16 |
1993-10-12 |
Degussa Aktiengesellschaft |
Tablets and granulates containing mesna as active substance
|
US5156850A
(en)
|
1990-08-31 |
1992-10-20 |
Alza Corporation |
Dosage form for time-varying patterns of drug delivery
|
IL99699A
(en)
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
JPH04230625A
(ja)
|
1990-12-27 |
1992-08-19 |
Standard Chem & Pharmaceut Corp Ltd |
噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
|
GB9104854D0
(en)
|
1991-03-07 |
1991-04-17 |
Reckitt & Colmann Prod Ltd |
Sustained release compositions
|
ATE120089T1
(de)
|
1991-05-20 |
1995-04-15 |
Marion Laboratories Inc |
Mehrschichtige zubereitung mit kontrollierter freisetzung.
|
ZA923474B
(en)
|
1991-05-20 |
1993-01-27 |
Marion Merrell Dow Inc |
Diltiazem formulation
|
US5286497A
(en)
|
1991-05-20 |
1994-02-15 |
Carderm Capital L.P. |
Diltiazem formulation
|
WO1992021333A2
(en)
|
1991-05-24 |
1992-12-10 |
Pharmavene, Inc. |
Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
|
CA2068402C
(en)
|
1991-06-14 |
1998-09-22 |
Michael R. Hoy |
Taste mask coatings for preparation of chewable pharmaceutical tablets
|
EP0520119A1
(de)
|
1991-06-17 |
1992-12-30 |
Spirig Ag Pharmazeutische Präparate |
Neue orale Diclofenaczubereitung
|
US5288505A
(en)
|
1991-06-26 |
1994-02-22 |
Galephar P.R., Inc., Ltd. |
Extended release form of diltiazem
|
US5326570A
(en)
|
1991-07-23 |
1994-07-05 |
Pharmavene, Inc. |
Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
|
DE69207863T2
(de)
|
1991-11-13 |
1996-06-05 |
Glaxo Canada |
Vorrichtung zur kontrollierten Wirkstoffreigabe
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5286493A
(en)
|
1992-01-27 |
1994-02-15 |
Euroceltique, S.A. |
Stabilized controlled release formulations having acrylic polymer coating
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5273760A
(en)
|
1991-12-24 |
1993-12-28 |
Euroceltigue, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5160742A
(en)
|
1991-12-31 |
1992-11-03 |
Abbott Laboratories |
System for delivering an active substance for sustained release
|
US5167964A
(en)
|
1992-02-14 |
1992-12-01 |
Warner-Lambert Company |
Semi-enteric drug delivery systems and methods for preparing same
|
WO1993017673A1
(en)
|
1992-03-03 |
1993-09-16 |
Top Gold Pty., Limited |
Sustained release analgesics
|
US5233987A
(en)
|
1992-07-09 |
1993-08-10 |
Empi, Inc. |
System and method for monitoring patient's compliance
|
US5324718A
(en)
|
1992-07-14 |
1994-06-28 |
Thorsteinn Loftsson |
Cyclodextrin/drug complexation
|
US5472711A
(en)
|
1992-07-30 |
1995-12-05 |
Edward Mendell Co., Inc. |
Agglomerated hydrophilic complexes with multi-phasic release characteristics
|
US5324351A
(en)
|
1992-08-13 |
1994-06-28 |
Euroceltique |
Aqueous dispersions of zein and preparation thereof
|
CA2144751C
(en)
|
1992-09-23 |
2001-05-01 |
George Paradissis |
Multi-vitamin and mineral supplement for pregnant women
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
US5376384A
(en)
|
1992-12-23 |
1994-12-27 |
Kinaform Technology, Inc. |
Delayed, sustained-release pharmaceutical preparation
|
IL110014A
(en)
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
WO1995003052A1
(en)
|
1993-07-22 |
1995-02-02 |
Warner-Lambert Company |
Controlled release tacrine drug delivery systems and methods for preparing same
|
US5521208A
(en)
|
1993-07-29 |
1996-05-28 |
Alcon Laboratories, Inc. |
Compositions and methods for the treatment of the metabolically impaired and for improved compliance
|
US5370878A
(en)
|
1993-09-30 |
1994-12-06 |
Hallmark Pharmaceuticals, Inc. |
Method for preparing a direct compression granulated acetaminophen composition
|
DE69432976D1
(de)
|
1993-11-02 |
2003-08-28 |
U D Testing Inc |
Verffahren zum überwachen der befolgung einer vorgeschriebenen medikation durch einen patienten
|
US5547878A
(en)
|
1993-11-02 |
1996-08-20 |
Kell; Michael |
Method of monitoring patient compliance with medications prescriptions
|
US5451409A
(en)
|
1993-11-22 |
1995-09-19 |
Rencher; William F. |
Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
|
US5500227A
(en)
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
US5597072A
(en)
|
1993-12-17 |
1997-01-28 |
Bogart, Delafield, Ferrier Inc. |
Totally interactive patient compliance method
|
US5407687A
(en)
|
1994-02-22 |
1995-04-18 |
Glaxo Inc. |
Ranitidine solid dosage form
|
US5374759A
(en)
|
1994-03-22 |
1994-12-20 |
Siltech Inc. |
Silicone esters of hydroxy acid
|
US5395626A
(en)
|
1994-03-23 |
1995-03-07 |
Ortho Pharmaceutical Corporation |
Multilayered controlled release pharmaceutical dosage form
|
US5658590A
(en)
|
1995-01-11 |
1997-08-19 |
Eli Lilly And Company |
Treatment of attention-deficit/hyperactivity disorder
|
US5661123A
(en)
|
1995-01-17 |
1997-08-26 |
Nestec, Ltd. |
Enteral composition for malabsorbing patients
|
CA2223629A1
(en)
|
1995-07-14 |
1997-02-06 |
Nicholas Robert Pope |
Therapeutic use of d-threo-methylphenidate
|
GB9514451D0
(en)
|
1995-07-14 |
1995-09-13 |
Chiroscience Ltd |
Sustained-release formulation
|
MXPA98000395A
(es)
|
1995-07-14 |
2005-04-29 |
Medeva Europ Ltd |
Composicion que comprende d-treo-metilfenidato y otra droga.
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
US5922736A
(en)
|
1995-12-04 |
1999-07-13 |
Celegene Corporation |
Chronic, bolus administration of D-threo methylphenidate
|
US5773031A
(en)
|
1996-02-27 |
1998-06-30 |
L. Perrigo Company |
Acetaminophen sustained-release formulation
|
AU695734B2
(en)
|
1996-07-08 |
1998-08-20 |
Penwest Pharmaceuticals Co. |
Sustained release matrix for high-dose insoluble drugs
|
AU3909597A
(en)
|
1996-08-16 |
1998-03-06 |
Alza Corporation |
Dosage form for providing ascending dose of drug
|
PT932388E
(pt)
|
1996-09-30 |
2006-07-31 |
Alza Corp |
Forma de dosagem e metodo para administracao de farmacos
|
US5851579A
(en)
|
1996-10-28 |
1998-12-22 |
Eastman Chemical Company |
Aqueous enteric coating compositions
|
US6919373B1
(en)
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
WO1998023263A1
(en)
|
1996-11-25 |
1998-06-04 |
Alza Corporation |
Ascending-dose dosage form
|
DE19718012C1
(de)
|
1997-04-29 |
1998-10-08 |
Jenapharm Gmbh |
Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe
|
US5840329A
(en)
|
1997-05-15 |
1998-11-24 |
Bioadvances Llc |
Pulsatile drug delivery system
|
US5885616A
(en)
|
1997-08-18 |
1999-03-23 |
Impax Pharmaceuticals, Inc. |
Sustained release drug delivery system suitable for oral administration
|
FR2772615B1
(fr)
*
|
1997-12-23 |
2002-06-14 |
Lipha |
Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
|
US5945123A
(en)
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
US6372254B1
(en)
|
1998-04-02 |
2002-04-16 |
Impax Pharmaceuticals Inc. |
Press coated, pulsatile drug delivery system suitable for oral administration
|
EP1083879B1
(en)
|
1998-06-03 |
2004-09-29 |
Alza Corporation |
Devices for providing prolonged drug therapy
|
SE9803871D0
(sv)
*
|
1998-11-11 |
1998-11-11 |
Pharmacia & Upjohn Ab |
Therapeutic method and formulation
|
DE19845358A1
(de)
|
1998-10-02 |
2000-04-06 |
Roehm Gmbh |
Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
|
US6322819B1
(en)
|
1998-10-21 |
2001-11-27 |
Shire Laboratories, Inc. |
Oral pulsed dose drug delivery system
|
US20060240105A1
(en)
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
US20090297597A1
(en)
|
1998-11-02 |
2009-12-03 |
Gary Liversidge |
Modified Release Ticlopidine Compositions
|
PL205109B1
(pl)
|
1998-11-02 |
2010-03-31 |
Elan Pharma Int Ltd |
Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie
|
US20080118556A1
(en)
|
1998-11-02 |
2008-05-22 |
Elan Corporation, Plc |
Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone
|
WO2008079102A1
(en)
|
2005-05-10 |
2008-07-03 |
Elan Corporation, Plc |
Modified release loxoprofen compositions
|
US20090297602A1
(en)
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
AR023700A1
(es)
|
1998-11-12 |
2002-09-04 |
Smithkline Beecham Plc |
Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
|
US20030153607A1
(en)
|
1998-11-12 |
2003-08-14 |
Smithkline Beecham P.L.C. |
Novel composition and use
|
US6673367B1
(en)
|
1998-12-17 |
2004-01-06 |
Euro-Celtique, S.A. |
Controlled/modified release oral methylphenidate formulations
|
US7083808B2
(en)
|
1998-12-17 |
2006-08-01 |
Euro-Celtique S.A. |
Controlled/modified release oral methylphenidate formulations
|
US6419960B1
(en)
*
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
WO2000059481A1
(en)
|
1999-04-06 |
2000-10-12 |
Pharmaquest Ltd. |
PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT
|
US6627223B2
(en)
|
2000-02-11 |
2003-09-30 |
Eurand Pharmaceuticals Ltd. |
Timed pulsatile drug delivery systems
|
DE10013029A1
(de)
|
2000-03-17 |
2001-09-20 |
Roehm Gmbh |
Mehrschichtige Arzneiform für die Colonfreigabe
|
EP1282406A1
(en)
|
2000-03-31 |
2003-02-12 |
Nycomed Austria GmbH |
Pharmaceutical kit comprising midodrine as an active drug substance
|
US6761904B2
(en)
|
2000-03-31 |
2004-07-13 |
Nycomed Austria Gmbh |
Pharmaceutical kit comprising midodrine as active drug substance
|
DE60107399D1
(de)
|
2000-03-31 |
2004-12-30 |
Nycomed Austria Gmbh Linz |
Pharmazeutische zusammensetzung mit gesteuerter freigabe enthaltend midodrin und/oder desglymidodrin
|
US7070803B2
(en)
|
2000-03-31 |
2006-07-04 |
Nycomed Austria Gmbh |
Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine
|
AU2001263006A1
(en)
|
2000-05-18 |
2001-11-26 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
US20020147232A1
(en)
|
2000-05-26 |
2002-10-10 |
Claus Sundgreen |
Pharmaceutical compositions comprising desglymidodrine as an active drug substance
|
CA2409950A1
(en)
|
2000-05-26 |
2001-11-29 |
Nycomed Austria Gmbh |
Pharmaceutical compositions comprising desglymidodrine as an active drug substance
|
US20020082939A1
(en)
|
2000-10-25 |
2002-06-27 |
Clark George Phillip |
Fulfilling a request for an electronic book
|
US6344215B1
(en)
*
|
2000-10-27 |
2002-02-05 |
Eurand America, Inc. |
Methylphenidate modified release formulations
|
ATE380022T1
(de)
|
2001-01-31 |
2007-12-15 |
Evonik Roehm Gmbh |
Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen
|
JP4754725B2
(ja)
|
2001-06-20 |
2011-08-24 |
ヤンマー株式会社 |
農作業機
|
CA2448558A1
(en)
|
2001-07-10 |
2003-01-23 |
Teva Pharmaceutical Industries, Ltd. |
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
|
US6638533B2
(en)
*
|
2002-01-03 |
2003-10-28 |
George Krsek |
Pulse dosage formulations of methylphenidate and method to prepare same
|
DE10214002A1
(de)
|
2002-03-27 |
2003-10-09 |
Roehm Gmbh |
Pharmazeutische Formulierung für den Wirkstoff Budesonid
|
DE10250543A1
(de)
|
2002-10-29 |
2004-05-19 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform
|
GB0228441D0
(en)
|
2002-12-05 |
2003-01-08 |
Ares Trading Sa |
Splice variant
|
US7988993B2
(en)
|
2002-12-09 |
2011-08-02 |
Andrx Pharmaceuticals, Inc. |
Oral controlled release dosage form
|
US9107804B2
(en)
|
2002-12-10 |
2015-08-18 |
Nortec Development Associates, Inc. |
Method of preparing biologically active formulations
|
JP4865330B2
(ja)
|
2002-12-13 |
2012-02-01 |
デュレクト コーポレーション |
経口ドラッグデリバリーシステム
|
DE10307386A1
(de)
|
2003-02-21 |
2004-09-09 |
Dieter Wildfang Gmbh |
Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil
|
US8906413B2
(en)
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
EP1680110B1
(en)
|
2003-11-04 |
2011-01-05 |
Supernus Pharmaceuticals, Inc. |
Once daily dosage forms of trospium
|
ES2261006B1
(es)
*
|
2004-06-10 |
2007-11-01 |
Laboratorios Rubio, S.A. |
Pellet multicapa de liberacion controlada de metilfenidato.
|
CA2601716C
(en)
|
2004-06-25 |
2011-05-31 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia
|
DE102004035936A1
(de)
|
2004-07-23 |
2006-03-16 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform
|
DE102005000719A1
(de)
*
|
2005-01-03 |
2006-07-20 |
Nextpharma Gmbh |
Pharmazeutische Zusammensetzung zur kontrollierten Freisetzung von ß-Lactam-Antibiotika in Kombination mit ß-Lactamase-Inhibitoren
|
MX2007008833A
(es)
|
2005-01-21 |
2008-03-25 |
Pharmanova Inc |
Formulaciones farmaceuticas y metodos de uso.
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
WO2007070082A1
(en)
|
2005-05-10 |
2007-06-21 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising teprenone
|
US20110064803A1
(en)
|
2005-05-10 |
2011-03-17 |
Elan Pharma International Limited. |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
DE102005024614A1
(de)
|
2005-05-25 |
2006-11-30 |
Röhm Gmbh |
Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
|
WO2007037790A2
(en)
|
2005-06-08 |
2007-04-05 |
Elan Corporation, Plc |
Modified release famciclovir compositions
|
DE112006001548T5
(de)
|
2005-06-12 |
2008-04-30 |
Elan Corp. Plc |
Ticlopidin-Zusammensetzungen mit modifizierter Freisetzung
|
US20070104789A1
(en)
*
|
2005-11-04 |
2007-05-10 |
Donald Spector |
Gastro-resistant and ethanol-resistant controlled-release formulations comprising hydromorphone
|
FR2897267A1
(fr)
*
|
2006-02-16 |
2007-08-17 |
Flamel Technologies Sa |
Formes pharmaceutiques multimicroparticulaires pour administration per os
|
US20070212414A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Penwest Pharmaceuticals Co. |
Ethanol-resistant sustained release formulations
|
US8846100B2
(en)
|
2006-05-12 |
2014-09-30 |
Shire Llc |
Controlled dose drug delivery system
|
FR2901478B1
(fr)
*
|
2006-05-24 |
2015-06-05 |
Flamel Tech Sa |
Forme pharmaceutique orale multimicroparticulaire a liberation prolongee
|
US20110212175A1
(en)
*
|
2006-10-30 |
2011-09-01 |
Hanall Biopharma Co., Ltd. |
Combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor
|
AU2007338631A1
(en)
|
2006-12-22 |
2008-07-03 |
Combinatorx, Incorporated |
Pharmaceutical compositions for treatment of parkinson's disease and related disorders
|
WO2008083442A1
(en)
|
2007-01-10 |
2008-07-17 |
Brc Operations Pty Limited |
Method for formulating combination medications for adhd
|
DE102007009243A1
(de)
|
2007-02-22 |
2008-09-18 |
Evonik Röhm Gmbh |
Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets
|
WO2008122967A2
(en)
|
2007-04-04 |
2008-10-16 |
Sigmoid Pharma Limited |
An oral pharmaceutical composition
|
US9700520B2
(en)
|
2007-09-21 |
2017-07-11 |
Evonik Roehm Gmbh |
PH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
|
US20110097395A1
(en)
|
2008-03-08 |
2011-04-28 |
Najib Babul |
Oral Pharmaceutical Compositions of Buprenorphine and Method of Use
|
ES2685468T3
(es)
|
2008-05-08 |
2018-10-09 |
Supernus Pharmaceuticals, Inc. |
Formulaciones de liberación controlada de alprazolam
|
CA2729015A1
(en)
*
|
2008-06-26 |
2009-12-30 |
Mcneil-Ppc, Inc. |
Coated particles containing pharmaceutically active agents
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
US20100151020A1
(en)
|
2008-12-16 |
2010-06-17 |
Vered Rosenberger |
Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate
|
US20120065221A1
(en)
|
2009-02-26 |
2012-03-15 |
Theraquest Biosciences, Inc. |
Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
|
EA031154B1
(ru)
|
2009-03-04 |
2018-11-30 |
Эмпликюре Аб |
Новый препарат, противодействующий злоупотреблению лекарством
|
MX2011009548A
(es)
|
2009-03-13 |
2011-12-14 |
Da Volterra |
Composiciones y metodos para la eliminacion de bacterias gram-negativas.
|
MX339408B
(es)
*
|
2010-03-09 |
2016-05-24 |
Alkermes Pharma Ireland Ltd |
Composiciones farmaceuticas entericas resistentes al alcohol.
|
AU2011236548A1
(en)
|
2010-04-07 |
2012-11-01 |
Lupin Limited |
Controlled release pharmaceutical compositions of tapentadol
|
WO2011133980A1
(en)
*
|
2010-04-23 |
2011-10-27 |
Subhash Desai |
Therapeutic formulation for reduced drug side effects
|
KR101873075B1
(ko)
*
|
2010-08-18 |
2018-06-29 |
에보니크 룀 게엠베하 |
하나 이상의 알긴산 염을 포함하는 위 내성 제약 또는 건강기능식품 제제
|
EP2632441A4
(en)
|
2010-10-29 |
2015-04-01 |
Relmada Therapeutics Inc |
(-) - 17- (CYCLOBUTYLMETHYL) MORPHINANE-3,14-DIOL COMPOSITIONS
|
EP2651892B1
(en)
|
2010-12-17 |
2015-04-22 |
Rhodes Technologies |
Low-temperature synthesis of methylphenidate hydrochloride
|
US8927010B2
(en)
|
2011-03-23 |
2015-01-06 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
DK4011364T3
(da)
*
|
2011-03-23 |
2024-03-18 |
Ironshore Pharmaceuticals & Dev Inc |
Fremgangsmåder og sammensætninger til behandling af ADD (Attention Deficit Disorder)
|
AR085840A1
(es)
|
2011-04-05 |
2013-10-30 |
Otsuka Pharma Co Ltd |
Medicamento que contiene un compuesto que es 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoxi]-1h-quinolin-2-ona
|
WO2013003622A1
(en)
|
2011-06-28 |
2013-01-03 |
Neos Therapeutics, Lp |
Dosage forms for oral administration and methods of treatment using the same
|
DE102012105528A1
(de)
|
2012-06-25 |
2014-01-02 |
Hennig Arzneimittel Gmbh & Co. Kg |
Arzneiform zur Freisetzung von Wirkstoffen
|
WO2014174387A1
(en)
*
|
2013-03-29 |
2014-10-30 |
Wockhardt Limited |
Modified release pharmaceutical compositions of dexmethylphenidate or salts thereof
|
EP3054929B1
(en)
|
2013-10-07 |
2020-08-05 |
Impax Laboratories, LLC |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
UA119335C2
(uk)
|
2013-12-11 |
2019-06-10 |
Айронвуд Фармасьютикалз, Інк. |
Композиції лінаклотиду з затриманим вивільненням
|
US20170196846A1
(en)
|
2014-06-06 |
2017-07-13 |
Rhodes Pharmaceuticals, L.P. |
Methods for treating attention deficit hyperactivity disorder with methylphenidate
|
JP2016006608A
(ja)
|
2014-06-20 |
2016-01-14 |
住友電気工業株式会社 |
管理方法、仮想マシン、管理サーバ、管理システム、及びコンピュータプログラム
|
CA2910865C
(en)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions and methods for reducing overdose
|
CA2936741C
(en)
|
2014-10-31 |
2018-11-06 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
DE102015000795A1
(de)
|
2015-01-23 |
2016-07-28 |
Se Tylose Gmbh & Co. Kg |
Reversibel vernetzte Celluloseether und Verfahren zu deren Herstellung durch selektive Oxidation von vicinalen OH-Gruppen
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|